Labyrinth Assessment/Behavioral Servs LABS

Labyrinth Assessment/Behavioral Servs LABS is an addiction-treatment facility located in Malad City, ID. The facility's programming is outpatient (Outpatient, Dual Dx), not residential. What follows is an orientation — not a review — to the practical questions worth asking before admission.

Care levels at Labyrinth Assessment/Behavioral Servs LABS

On care levels specifically: Labyrinth Assessment/Behavioral Servs LABS is an outpatient-focused program (Outpatient, Dual Dx) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. What that means in practice is that matching Labyrinth Assessment/Behavioral Servs LABS to the right clinical situation depends on whether you or a loved one needs the level of care this facility actually offers — which is a clinician's judgment, not a facility's sales pitch.

Insurance and payment

On insurance specifically: Labyrinth Assessment/Behavioral Servs LABS accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. Before admission, ask the facility's utilization-review team for a written Verification of Benefits — not verbal assurance, which is where most post-treatment financial surprises come from. Also ask for specific plan-level confirmation, not carrier-level (e.g., "your Aetna PPO plan" not just "Aetna").

Specialty programming

The facility's documented specialty programming includes: Adolescents, Adult women, Adult men. If that matches what you or your family member need, great — and worth asking specifically about what the programming looks like day-to-day (how many hours per week of specialty-specific content, who leads it, what credentials they hold).

Before you call

Before admission to Labyrinth Assessment/Behavioral Servs LABS, three questions consistently produce the most useful information: (1) which ASAM level of care are you treating me at, and what is the clinical rationale; (2) can you send me a written Verification of Benefits for my specific insurance plan; (3) what is your policy on medication-assisted treatment for opioid use disorder — specifically, do you continue patients on buprenorphine or methadone during residential programming. If the clinical situation involves opioid use disorder, confirm explicitly whether Labyrinth Assessment/Behavioral Servs LABS offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.